Get started
TILRAY BRANDS INCTILRAY BRANDS INCTILRAY BRANDS INC

TILRAY BRANDS INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

2HQ trade ideas

TLRY - Smoke But No Fire As Yet 🔥Here's another stock that rekt plenty a punter not realising just how deep trends can go. I've been saying for a long time TLRY will go DEEP and has now passed my $3.5 target. I did have a much lower target but I think it may be close to bottoming here. Plenty of bullish divergence coming in but no excitement in the price as yet so smoke but no fire as yet. If indexes do break out then I think TLRY will pump hard but if they fall then I will revert back to my deeper target of $0.6. We'll be looking closely at this one, could be a rocket... 🧑🏻‍🚀🚀🚀 Not advice.
NASDAQ:TLRYLong
by dRends35
1
🟨 Climax Run - $TLRY exampleI have covered this in my education blog, but here is a great example of a Climax Run Stock Checklist ✅ Price looks almost vertical ❌ Run occurs after at least 18 weeks of the first base. (This run is 5 weeks after first base) ✅ Rapid advancement +180% ✅ Last 8 days before drop was 7 out of 8 days up ✅ Last 2 trading days we saw the largest trading range ❌ Stock is not extended above 200d MA - since no 200 days of trading (early IPO) ❌ No Stock splits
NASDAQ:TLRY
by TintinTrading
2
TLRY earnings on MondayTLRY Q2 November 2022 earnings are on Monday 1/9/2023 at 7am. Tilray Brands (TLRY) reported a Q1 August 2022 loss of $0.08 per share on revenue of $153.2 million. The consensus estimate was a loss of $0.06 per share on revenue of $155.7 million. Revenue fell 8.8% compared to the same quarter a year ago. The company said it continues to expect Adjusted EBITDA of $70 million to $80 million for the year ending December 31, 2022. I'm posting this as a long because of the higher probability, lower risk, current technical setup entry point. TLRY at $2.75 is near its major support level on the TTCATR(beta) indicator, plus there's a bullish cross setup on piRSI indicator now also. Here's TLRY levels on the 1-day chart: Q2 November 2022 consensus: EPS = -$0.05 Revenue = $158.29M SMA200 = $4.07 SMA20 Triangular Trend Channel ATR(beta): top = $4.92 R3 = $4.62 R2 = $4.32 R1 = $4.03 pivot = $3.73 S1 = $3.43 S2 = $3.13 S3 = $2.83 bottom = $2.53 Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum BBMC - bollinger bands TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.com
NASDAQ:TLRYLong
by Options360
4
TLRY LongThe Play TLRY has had a 30%+ pullback from the recent highs stemming from the December 2, 2022, recent legislation that was signed by President Biden. The strategy is to take advantage of a likely 10-15% rally in the short term. Legislation: Highlights After unanimous consent from the Senate, President Biden signed into law the Medical Marijuana and Cannabidiol Research Expansion Act, an act aimed at providing federal support to facilitate research of cannabis and its potential health benefits. Legislation: Who’s Impacted The medical community, including researchers in the bio-medical field, and those interested in the pharmaceutical applications of cannabis, as well as patients in need of more treatment options. The research will also help inform lawmakers, cannabis businesses, and consumers. Things to look out for The S&P500, or the general market, is in an overall bearish trend and showing signs of resistance after a recent 2-month bull rally. About the company Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia, and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.
NASDAQ:TLRYLong
by KyleUSA
TLRY - Looks Set To Break Out With Indexes 🚀🌒TLRY appears to be consolidating my previous first target 1:0.618 @ $3.42 just as NDX looks set to break out and so I think this is the anchoring fib that will prove to either be the bottom or a significant low. Also earnings is coming up shortly and would you believe the 1:1 fib time extension for this 3 wave pattern is almost exactly at earnings. Its as if its been scripted 😄. So I think TLRY is about to rocket 🚀. Bought LEAP puts due to high IV which can pay for my calls, alternatively can buy the stock. Not advice.
NASDAQ:TLRYLong
by dRends35
32